Viamet Pharmaceuticals, Inc., a world leader in the development of best-in-class therapies targeting metalloenzymes, announced today that Robert Schotzinger, M.D., Ph.D., President and CEO of Viamet, will present an overview of the Company at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 8, beginning at 11:30 a.m. Pacific Time. The presentation will be held in the Elizabethan Ballroom at the Westin St. Francis Hotel.
